Global Retirement Partners LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 7,610 shares of the company's stock, valued at approximately $1,808,000.
Several other large investors also recently bought and sold shares of CAH. University of Texas Texas AM Investment Management Co. acquired a new position in Cardinal Health in the 4th quarter valued at about $26,000. Bank of Jackson Hole Trust purchased a new stake in shares of Cardinal Health during the fourth quarter worth about $27,000. Jones Financial Companies Lllp grew its holdings in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after buying an additional 14,034 shares in the last quarter. Palladiem LLC acquired a new position in shares of Cardinal Health in the fourth quarter valued at approximately $28,000. Finally, Indiana Trust & Investment Management Co purchased a new position in shares of Cardinal Health during the first quarter valued at approximately $29,000. Institutional investors and hedge funds own 87.17% of the company's stock.
Cardinal Health Stock Performance
Shares of NYSE:CAH opened at $235.68 on Tuesday. The stock has a 50-day simple moving average of $230.93 and a 200-day simple moving average of $217.34. The stock has a market capitalization of $54.81 billion, a P/E ratio of 32.60, a PEG ratio of 1.26 and a beta of 0.49. Cardinal Health, Inc. has a 1 year low of $145.87 and a 1 year high of $258.30.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. During the same quarter last year, the firm posted $2.08 earnings per share. Cardinal Health's revenue for the quarter was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Analysts predict that Cardinal Health, Inc. will post 12.55 earnings per share for the current year.
Cardinal Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health's dividend payout ratio (DPR) is 28.49%.
Analysts Set New Price Targets
Several equities analysts recently weighed in on CAH shares. Morgan Stanley increased their target price on Cardinal Health from $255.00 to $265.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 12th. Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, July 4th. Leerink Partners set a $292.00 target price on shares of Cardinal Health in a research report on Tuesday, August 11th. Evercore reaffirmed an "outperform" rating and set a $270.00 price target on shares of Cardinal Health in a research report on Wednesday, August 12th. Finally, Mizuho increased their price target on shares of Cardinal Health from $240.00 to $250.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 12th. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, Cardinal Health currently has a consensus rating of "Moderate Buy" and an average target price of $265.93.
Read Our Latest Stock Report on CAH
Cardinal Health Company Profile
(
Free Report)
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
